Kodiak Sciences, Inc. (KOD)
22.25
-0.42
(-1.83%)
USD |
NASDAQ |
Mar 20, 16:00
22.69
+0.44
(+1.98%)
After-Hours: 20:00
Kodiak Sciences Research and Development Expense (Quarterly) : 50.48M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Tango Therapeutics, Inc. | 31.62M |
| Revolution Medicines, Inc. | 292.61M |
| ACADIA Pharmaceuticals, Inc. | 84.76M |
| Amicus Therapeutics, Inc. | 23.74M |
| Insmed, Inc. | 254.91M |